This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: University of Ghent, Vib Vzw, Universiteit Gent. Active years: 2020-2026.
Company Filing History:



Years Active: 2020-2026
Title: Anna Depicker: Innovator in Oral Protein Delivery
Introduction
Anna Depicker is a prominent inventor based in Schelderode, Belgium. She has made significant contributions to the field of recombinant protein production and oral pharmaceutical formulations. With a total of 3 patents, her work focuses on innovative solutions for treating gastro-intestinal and buccal disorders.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Means and methods for oral protein delivery." This invention relates to the production of recombinant proteins in host cells, specifically aimed at creating oral pharmaceutical formulations. These formulations utilize the culture medium of a recombinant host that secretes a recombinant protein, making them useful for both treatment and prophylactic purposes. Another notable patent is "Protective anti-ETEC antibody," which describes an antibody designed to protect against ETEC infection through passive immunization. This invention involves a VHH grafted on an IgA scaffold, produced in plant seeds, which can be administered in food or feed to provide protection against ETEC infection.
Career Highlights
Throughout her career, Anna has worked with notable organizations such as Vib Vzw and Ghent University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Anna has collaborated with esteemed colleagues, including Vikram Virdi and Nico Callewaert. These partnerships have further enriched her research and innovation efforts.
Conclusion
Anna Depicker stands out as a leading inventor in the field of oral protein delivery, with her innovative patents paving the way for advancements in medical treatments. Her contributions continue to impact the scientific community positively.